Analysts this week were busy upgrading, downgrading and changing price targets on a variety of companies.
Starbucks SBUX was upgraded to buy at BTIG, which expects a strong sales-and-earnings recovery on the back of a quick return of customers. Analyst Peter Saleh maintained his price target of $130 on the coffee-bar giant.
MGM Resorts International (MGM) - Get Report rose after Jefferies analyst David Katz upgraded shares of the casino and entertainment company to buy from hold and raised his price target to $50 from $36.
China's stocks have been downgraded on a one-year outlook by analysts at BCA Research, who cited "high risk" policy overtightening and weakening technical indicators as their reasons, as the government pulls back policy support this year.
Evercore ISI analyst Liisa Bayko downgraded Translate Bio (TBIO) - Get Report to in line from outperform with a price target of $21, down from $24. The company said its cystic fibrosis treatment provided no marked increases in lung function.
Price Target Change
Wells Fargo analyst Ike Boruchow raised his price target for Gap (GPS) - Get Report to $40 a share from $32 after meeting with the clothing retailer's management. Boruchow kept his overweight rating on the stock.